the_newsbeagle writes Pharmaceutical research for neuropsychiatric disorders hasn’t produced many breakthroughs lately, which may explain why there’s so much excitement around “electroceutical” research. That buzzy new field encompasses deep brain stimulation (DBS), in which an implanted stimulator sends little jolts through the neural tissue. DBS has become an accepted therapy for Parkinson’s and other motor disorders, even though researchers haven’t really understood how it works. Now, new research may have found the mechanism of action in Parkinson’s patients: The stimulation reduces an exaggerated synchronization of neuron activity in the motor cortex.
Read more of this story at Slashdot.